Loading...
 
Toggle Health Problems and D

Gastric Cancer, Vitamin D, VDR, UV - many studies


Observation: VDR down and up-regulation, Sunlight/UVB is good


Those with Gastric Cancer were 3X more likely to have low Vitamin D - meta-analysis Nov 2022

Correlation between Serum 25-Hydroxyvitamin D Levels and Gastric Cancer: A Systematic Review and Meta-Analysis
Curr Oncol . 2022 Nov 2;29(11):8390-8400. doi: 10.3390/curroncol29110661.
Xing Liu 1 , Yueyue Zhou 1 , Xihuan Zou 1

Image
The purpose of this meta-analysis was to evaluate the relationship between serum 25-hydroxyvitamin D[25(OH)D] levels and gastric cancer. PubMed, Embase, Cochrane Library, Web of Science, The China Academic Journals full-text database, Wanfang Database of Chinese Academic Journals, VIP Chinese Science and Technology Periodicals database, and Chinese Biomedical Literature database were systematically searched. Case-control studies on the correlation between serum 25-hydroxyvitamin D levels and gastric cancer were retrieved, and the data extracted were analyzed. The results of 9 case-control studies containing 671 patients showed that serum 25(OH)D levels in the gastric cancer group were lower than those in the control group (weighted mean difference (WMD) = -8.90, 95% confidence interval (CI): -11.5, -6.32, p < 0.01);
the risk of vitamin D deficiency in the gastric cancer group was higher than that in the control group (Odds ratio = 3.09, 95% CI: 1.96, 4.87, p < 0.01). The serum 25(OH)D levels in patients with well and moderately differentiated gastric cancer were higher than those in patients with poorly differentiated gastric cancer (WMD = -3.58, 95% CI: -6.41, -0.74, p = 0.01). Thus, low levels of vitamin D may increase the risk of gastric cancer. Systematic review registration: PROSPERO CRD42022327942.
 Download the PDF from VitaminDWiki


Less gastric cancer if more sun – meta-analysis Sept 2022

Relationship of vitamin D intake, serum 25(OH) D, and solar ultraviolet-B radiation with the risk of gastric cancer: A meta-analysis
J Cancer Res Ther. 2022 Sep;18(5):1417-1424. doi: 10.4103/jcrt.jcrt_527_21.
Xia Chen 1 , Longquan Li 1 , Yuan Liang 1 , Taobi Huang 1 , Huiyun Zhang 1 , Shanlin Fan 2 , Weiming Sun 3 , Yuping Wang 1

The purpose of this meta-analysis was to investigate whether vitamin D intake, serum 25(OH) D, and solar ultraviolet-B (UVB) radiation have an effect on the incidence of gastric cancer. Keyword searches of online databases were performed from January 2000 to October 2020. A comprehensive analysis was conducted on the relationship of vitamin D intake, serum 25(OH) D level, and UVB radiation with the risk of gastric cancer.
A total of 11 articles were included and analyzed. When the highest and lowest intake levels of vitamin D were compared, *no significant association was found between vitamin D intake and gastric cancer incidence [effect size (ES): 1, 95% confidence interval (CI): 0.86-1.16, P = 0.983]. The ES of serum 25(OH) D level and gastric cancer incidence was 0.93 (95% CI: 0.77-1.11, P = 0.4), suggesting no relationship between 25(OH) D level and gastric cancer risk. High UVB radiation was associated with lower gastric cancer incidence (ES: 0.86, 95% CI: 0.84-0.89, P = 0) compared with low UVB radiation.
Vitamin D intake and serum 25(OH) D level had no relationship with the risk of gastric cancer.
However, an inverse association was found between solar UVB radiation and gastric cancer incidence.


Vitamin D IS associated with Gastric Cancer (preprint) meta-analysis Nov 2021

Vitamin D and gastric cancer: A systematic review and meta-analysis
Research Square DOI: https://doi.org/10.21203/rs.3.rs-1067367/v1
Xi Zhao ( B 1032075378 at qq.com )

Image
Object:
To explore the correlation between serum vitamin D level and the occurrence and pathological grade of gastric cancer.
Data sources:
Search the PubMed, Embase, Web of Science, Cochrane, Chinese Journal Full-text Database (CNKI), Wanfang Science and Technology Journal Full-text Database, Chinese Science and Technology Journal Full-text Database (VIP), Chinese Biomedical Literature Database (CBM), All articles about the correlation between serum vitamin D levels and gastric cancer published before July 2021.
Results:
10 trials with 1159 cases of gastric cancer patients and 33387 cases of normal control patients were analyzed. The serum vitamin D level of the gastric cancer group(15.56±7.46ng/ml) was lower than the control group (17.60±1.61 ng/ml), and the difference was statistically significant (MD=-8.28, 95%CI: -14.32~-2.23, P <0.00001). The patients with gastric cancer clinical stage NI/IV(16.19±8.04ng/ml) is lower than that of patients with stage I/II (19.61 ±9.61 ng/ml), and the patients with low differentiation of gastric cancer is (17.5± 9.5ng/ml) is lower than that of well or moderately differentiated patients (18.04±7.92ng/ml), and the patients with lymph node metastasis (19.41 ±8.63ng/ml) is lower than that of patients without lymph node metastasis (20.65± 7.96ng/ml), the difference is statistically significant;
Conclusions:
Vitamin D levels are negatively correlated with the occurrence of gastric cancer. Vitamin D levels are significantly correlated with different clinical stages, degrees of differentiation and lymph node metastasis, suggesting that low vitamin D levels may be a predictor of poor prognosis in gastric cancer.
 Download the PDF from VitaminDWiki


UVB (sun) reduced Gastric Cancers by 36 percent - Feb 2018

Annual Ambient UVB at Wavelengths that Induce Vitamin D Synthesis is Associated with Reduced Esophageal and Gastric Cancer Risk: A Nested Case–Control Study
Photochemistry and Photobiology https://doi.org/10.1111/php.12915
Fiona O'Sullivan, Jos van Geffen, Michiel van Weele, Lina Zgaga

Vitamin D has been shown to be beneficial at reducing the risk of cancer; however, studies examining esophageal and gastric cancer have been scarce and findings inconsistent. The UK Biobank cohort was used for this nested case–control study (N = 3732). Primary, incident esophageal and gastric cancer cases diagnosed after recruitment were identified via linkage to National Cancer Registries. Tropospheric Emissions Monitoring Internet Service database was used to calculate ambient annual UVB dose (D-UVB). Conditional logistic regression was used to investigate the relationship between annual ambient D-UVB and risk of esophageal and gastric cancer, and odds ratios (ORs) are reported. In total, 373 esophageal and 249 gastric cancer cases and 3110 age- and gender-matched controls were included in the study. We found a strong inverse association between annual ambient D-UVB and odds of developing esophageal or gastric cancer: Compared to the lowest tertile, OR for the highest tertile was 0.64 (95%CI:0.51–0.79) in adjusted analysis.
The association was strengthened when restricted to esophageal cancer (OR = 0.60; 95%CI:0.45–0.80) and
esophageal adenocarcinoma cases (OR = 0.48; 95%CI: 0.34–0.68). Similar results were found in unadjusted and stratified analysis. In conclusion, ambient UVB radiation is inversely associated with the development of esophageal and gastric cancer, even in a high-latitude country.
 Download the PDF from Sci-hub via VitaminDWiki


Vitamin D not associated with Gastric Cancer - meta-analysis Aug 2015

Vitamin D intake, serum Vitamin D levels, and risk of gastric cancer: A systematic review and meta-analysis
J Res Med Sci. 2015 Aug; 20(8): 790–796. doi: 10.4103/1735-1995.168404
Saeid Khayatzadeh,1,2 Awat Feizi,3 Parvane Saneei,1,2 and Ahmad Esmaillzadeh1,2

We are aware of no systematic review or meta-analysis of published findings about the association between Vitamin D status and risk of gastric cancer (GC). We systematically reviewed the current evidence on the association between Vitamin D intake as well as serum 25-hydroxy Vitamin D (25(OH)D) levels and risk of GC.
Materials and Methods:
Published evidence in this area was searched to August 2014 through the use of ISI Web of Science, Scopus, PubMed/Medline, Ovid Database, EMBASE, and Google Scholar for relevant articles by cross-referencing. Seven articles had reported odds ratios (ORs) or relative risks (RR) as their effect size; four papers had reported the ORs between Vitamin D intake and GC; and three papers had reported the association between serum 25(OH)D and risk of GC.
Results:
Pooled effect size for comparison of highest versus lowest intakes of Vitamin D was 1.09 (95% confidence interval CI: 0.94, 1.25; P = 0.26) indicating no significant association between Vitamin D intake and risk of GC. We failed to find a significant association between serum Vitamin D levels and risk of GC (OR: 0.92; 95% CI: 0.74-1.14; P = 0.429). Among men, the pooled effect size or highest versus lowest category of serum Vitamin D levels was 0.92 (95% CI: 0.71, 1.18, P = 0.49). The corresponding figures in women were 1.04 and 95% CI: 0.74-1.47 (P = 0.80).
Conclusion:
We found no evidence for the significant association between Vitamin D status and risk of GC. However, due to limited data in this field, further studies are required to reach a definite conclusion.
 Download the PDF from VitaminDWiki


Genes restrict how much Vitamin D gets to Gastric Cancer - 2021

Vitamin D and Gastric Cancer: A Ray of Sunshine?
Cureus 13(9): e18275. doi:10.7759/cureus.18275
Suchitra Shah , Zafar Iqbal, Mohammed G. Alharbi , Harjeevan S. Kalra, Megha Suri, Nitin Soni, Nkiruka Okpaleke, Shikha Yadav, Pousette Hamid

Gastric cancer (GC) is one of the most aggressive malignancies, currently ranking third among cancers leading to death worldwide. Despite the recent advancements in GC research, it is most often diagnosed during the terminal stages and with limited treatment modalities contributing to its poor prognosis and a lower survival rate.

Much research has provided conflicting results between a vitamin D deficient status and the development of GC. Vitamin D is a well-known and essential hormone classically known to regulate calcium and phosphate absorption, enabling adequate mineralization of the skeletal system. However, the function of vitamin D is multidimensional. It possesses unique roles, including acting as antioxidants or immunomodulators while crossing the cell membrane, performing several intracellular functions, participating in gene regulation, and controlling the proliferation and invasion of cancer cells, including those of GC.

In light of this, it is imperative to analyze the causes of GC, review the factors that can be used to enhance the effectiveness of treatments, and discover the tools to determine prognosis, reduce mortality, and prevent GC development. In this review, we have summarized recent investigations on multiple associations between vitamin D and GC, emphasizing genetic associations, vitamin D receptors, and the prevalence of hormone deficiency in those developing this aggressive malignancy.

Conclusions - from pdf (VDR)

Several studies have been conducted to explore the relationship between vitamin D and GC. We observed a variety of correlations between vitamin D and GC. In most studies, GC patients have shown an increased prevalence of VDD, although few studies on VDD prevalence in GC patients are paradoxical. UVB radiation has been shown in most ecological studies to lessen the incidence and mortality of GC. An adequate vitamin D level has been associated with an increase in the survival rate of GC patients, and a low vitamin D level can be considered as a poor prognostic factor in GC.

Furthermore, variations in the VDR gene have been attributed to an increased risk of various malignancies, including GC. Many VDR gene polymorphisms are associated with the risk of GC. However, various research on VDR gene polymorphisms and GC risk have yielded inconsistent results.

Vitamin D exerts an anti-cancer effect by different mechanisms, such as regulating epigenetic pathways, upregulating the expression of miRNAs, boosting the action of cisplatin, stimulating TSGs, and regulating intracellular signal transduction. We also found that serum vitamin D is lower in the HP-positive patients than negative ones, and vitamin D deficient patients fail to eliminate HP. Based on the facts presented above, we may conclude that vitamin D is a protective factor in GC. It can be utilized as a promising technique to treat GC and increase survival rates by correcting the deficiency of vitamin D. However, additional studies are required to fully assess the genetic association of VDR in GC for a more profound knowledge of how to diagnose and treat the aggressive malignancy early and effectively to maximize the survival outcomes.
 Download the PDF from VitaminDWiki


VitaminDWiki VDR pages with CANCER in title (79 as of Oct 2022)

This list is automatically updated

Items found: 80
Title Modified
Breast cancer spreads to bone if poor vitamin D Receptor (no surprise) – Oct 2022 31 Oct, 2022
2X more Thyroid Cancer malignancy if less than 15 ng of vitamin D – June 2012 16 Sep, 2022
Cancers are associated with low vitamin D, poor vaccination response and perhaps poor VDR – July 2022 15 Aug, 2022
Poor prognosis of solid childhood cancers 14.7 X more likely with a poor Vitamin D Receptor – July 2022 27 Jul, 2022
Breast Cancer, Vitamin D, and genes – Welsh Nov 2021 09 Feb, 2022
How cancer is fought by Vitamin D (Ovarian this time) - Feb 2020 01 Nov, 2021
Lung Cancer is up to 7 X more deadly if poor vitamin D genes – Oct 2021 25 Oct, 2021
Cancers and Vitamin D Receptors, including change with race – Feb 2021 24 Oct, 2021
Breast Cancer reduces receptor and thus blocks Vitamin D to the cells – several studies 18 Oct, 2021
After lactation Vitamin D levels are low, increased risk of Breast Cancer, vitamin D should decrease risk – Aug 2021 20 Aug, 2021
Breasts process Vitamin D and change gene activation, might prevent breast cancer if given more Vit. D – July 2021 10 Jul, 2021
Vitamin D Receptor and Cancer 17 Feb, 2021
Oral Cancers - increased risk if low vitamin D or poor vitamin D genes 22 Jan, 2021
Colon cancer risk increases 30X if you have the worst vitamin D receptor mutation – Jan 2021 15 Jan, 2021
Book: Sunlight, UV, Vitamin D and Receptor, Skin and other Cancers - Dec 2020 09 Dec, 2020
Colorectal Cancer Patients 2.4 X more likely to have poor Vitamin D receptors (less D to cells) – April 2020 02 May, 2020
Colorectal cancer linked to poor Vitamin D Receptor (yet again) – Jan 2020 22 Jan, 2020
8 ways that Cancer might be prevented by Vitamin D - June 2019 26 Dec, 2019
Liver Cancer – higher risk if poor genes (Vitamin D receptor etc) – meta-analysis Dec 2019 14 Dec, 2019
Prostate Cancer associated with various genes, including Vitamin D Receptor and CYP24A1 – Nov 2019 15 Nov, 2019
Risk of Cancer increased if poor Vitamin D Receptor – meta-analysis of 73 studies Jan 2016 09 Nov, 2019
Cancer is leading cause of death - Vitamin D and Receptor activators help 09 Nov, 2019
Melanoma cancer growth slowed by increased Vitamin D Receptor (yet again) – Oct 2019 06 Nov, 2019
Breast cancer associated with Vitamin D Receptor (14th study) – Oct 2019 19 Oct, 2019
Colorectal Cancer risk increases when genes reduce the vitamin D levels – Aug 2019 23 Aug, 2019
Breast Cancer death 1.8 X more likely if poor Vitamin D Receptor – April 2019 29 Jul, 2019
Blood cell cancer is associated with a 3X worse Vitamin D Receptor – June 2019 14 Jun, 2019
Lung Cancer more likely if poor Vitamin D Receptor – meta-analysis June 2019 13 Jun, 2019
After breast cancer treatment 4,000 IU of Vitamin D was not enough to help if have poor Vitamin D receptor – June 2019 04 Jun, 2019
Effects of Resveratrol against Lung Cancer in mice – Nov 2017 28 Apr, 2019
The Role of Resveratrol in Cancer Therapy – Dec 2017 27 Apr, 2019
Good Vitamin D receptor reduced bladder cancer and cisplatin deaths – April 2019 11 Apr, 2019
A poor Vitamin D Receptor is associated with many cancers (oral cancer in this case) – Jan 2019 26 Mar, 2019
Breast Cancer and Vitamin D review – March 2018 17 Mar, 2019
Overview of Vitamin D Actions in Cancer – 31 page chapter in a book – 2018 15 Mar, 2019
Women with Breast Cancer were 16.9 times more likely to have a poor Vitamin D Receptor – Jan 2019 11 Feb, 2019
Risks of Colorectal Cancer, IBD, etc slightly increased if poor Vitamin D Receptor – Aug 2018 09 Dec, 2018
Ovarian Cancer risk reduced if higher vitamin D, more UVB, or better vitamin D receptor – Nov 2018 10 Nov, 2018
Cancer treatment by Vitamin D sometimes is restricted by genes – Oct 2018 01 Nov, 2018
Brain cancer in 175 countries related to low UVB and low vitamin D – Oct 2010 03 Oct, 2018
Pancreatic Cancer – live a year longer if have high vitamin D and good Vitamin D Receptor – Aug 2018 15 Aug, 2018
Endometriosis, Endometrial Cancer, and poor Vitamin D or Receptor – Aug 2018 08 Aug, 2018
Risk of colon cancer increases in mice with no Vitamin D receptor in colon - July 2018 07 Jul, 2018
Vitamin D receptor is essential for both normal and cancerous cells in the lab – June 2018 16 Jun, 2018
Active Vitamin D reduces Ovarian Cancer stem cells growth by 4X (via Vitamin D receptor in lab rat) – March 2018 28 Mar, 2018
Two chemicals increase the Vitamin D receptor and decrease the growth of breast cancer cells in the lab - March 2018 17 Mar, 2018
Ovarian Cancer in Asia is 1.5 X more likely if poor Vitamin D receptor – meta-analysis Dec 2017 14 Dec, 2017
Nonmelanoma Skin Cancer 2X more likely if poor Vitamin D Receptor – Oct 2017 19 Oct, 2017
Cancer and the Vitamin D Receptor, a primer – Sept 2017 01 Oct, 2017
Thyroid Cancer rate has increased 3X in 3 decades, Vitamin D Receptor decreases, Calcium increases – Aug 2017 26 Aug, 2017
Advanced Colon Cancer risk is doubled or halved with 1000 IU of Vitamin D, depends on Vitamin D Receptors – RCT May 2017 19 Aug, 2017
Cancer risks and Vitamin D Receptors – association is unclear – 2017 19 Aug, 2017
Increased Breast Cancer metastasis if low vitamin D or poor VDR – Feb 2016 09 Aug, 2017
Colon Cancer survival 3.1 X less likely if poor Vitamin D Receptor – Aug 2017 02 Aug, 2017
Lung Cancer patients were 2.4 times more likely to have a poor Vitamin D Receptor gene – July 2017 27 Jul, 2017
Pancreatic Cancer massively deregulates the local Vitamin D receptors and CPY24A1 – July 2014 25 Jul, 2017
Gastric Cancer 2.7 X more likely if poor Vitamin D Receptor (Chinese) – 2015 15 Jun, 2017
Skin Cancers, Vitamin D, Vitamin D Receptor and Genes – Jan 2015 17 Mar, 2017
Prostate cancer in black men is 1.6 times more likely if a poor Vitamin D Receptor – Feb 2017 06 Mar, 2017
2X more likely to survive a form of esophageal cancer in China if have good vitamin D receptor – Feb 2017 04 Mar, 2017
Urinary Bladder Cancer survival is associated with vitamin D receptor: 14 months vs 53 months – Oct 2015 02 Mar, 2017
Vitamin D receptor as a target for breast cancer therapy (abstract only) – Feb 2017 01 Mar, 2017
Ovarian Cancer 5.8 X more likely if both low vitamin D and Fok1 gene change – May 2013 27 Feb, 2017
Vitamin D receptor may suppress skin cancer – Dec 2013 27 Jan, 2017
Aggressive Prostate Cancer in blacks with low vitamin D – 7X more likely if added Calcium – Jan 2017 28 Dec, 2016
Breast Cancer was 4.6 times more likely if have a poor Vitamin D Receptor – Dec 2016 06 Dec, 2016
Vitamin D, Vitamin D Receptor and Cancer – Nov 2016 05 Dec, 2016
High PSA readings with Prostate Cancer 4 times more likely if poor Vitamin D receptor – March 2016 14 Nov, 2016
2X less prostate cancer in A-A with low Calcium is due vitamin D receptor gene – July 2013 14 Nov, 2016
Vitamin D receptor polymorphisms are risk factors for various cancers – meta-analysis Jan 2014 12 Nov, 2016
10 percent of colon cancer linked to Vitamin D Receptor – meta-analysis April 2012 23 Sep, 2016
Vitamin D Receptor role in Autoimmune Diseases and or cancers – Nov 2013 17 Mar, 2016
Skin cancer 20 percent more likely with some Vitamin D receptor gene polymorphisms – Oct 2015 06 Jan, 2016
Pancreatic Cancer treatment by calcipotriol (a synthetic vitamin D) improves outcome by 57 percent – Sept 2014 13 Dec, 2015
Poor Bladder Cancer survival associated with poor Vitamin D receptor – Oct 2015 18 Oct, 2015
Increased risk of some female cancers if low vitamin D (due to genes) – meta-analysis June 2015 03 May, 2015
Free vitamin D (VDR) may be more important than total for bladder cancer – March 2013 06 Jan, 2014
Genes breast cancer and vitamin D receptor - Sept 2010 08 Jul, 2013
Breast Cancer incidence change by 40 percent with vitamin D receptor genes – Oct 2012 08 Jul, 2013
Vitamin D receptor in breasts and breast cancer vary with race – March 2013 08 Jul, 2013

VitaminDWiki Cancer-Other pages with GASTRIC in the title (5 as of Oct 2022)

This list is automatically updated

Items found: 5

VitaminDWiki UV pages with Cancer in the title (29 as of Oct 2022)

This list is automatically updated

Items found: 29
Title Modified
Gastric Cancer, Vitamin D, VDR, UV - many studies 10 Nov, 2022
Vitamin D from the sun reduces the risk of internal cancers, but increases some skin cancers – Nov 2021 28 Nov, 2021
Most sunscreens actually increase the growth of skin cancer - May 2010 26 Apr, 2021
Some cancer rates are reduced when live at high altitude, but other cancers increase after a few generations – March 2021 27 Mar, 2021
Book: Sunlight, UV, Vitamin D and Receptor, Skin and other Cancers - Dec 2020 09 Dec, 2020
Breast Cancer risk reduced 17 percent by 1 hour of daily summer sun – meta-analysis Jan 2020 07 Jan, 2020
Brain cancer in 175 countries related to low UVB and low vitamin D – Oct 2010 03 Oct, 2018
UVA causes skin cancer, perhaps UVB (Vitamin D) prevents skin cancer – Jan 2017 27 Jan, 2017
Skin cancer (in mice) due to UV was prevented by vitamin D (active, topical) – June 2016 07 Jan, 2017
Getting little UV is associated with 15 types of Cancer – Jan 2012 26 Aug, 2016
A review of the evidence regarding the solar ultraviolet-B-vitamin D-cancer hypothesis - Oct 2012 08 Jan, 2016
Fewer heart attacks, hip fractures and deaths if more skin cancer – Sept 2013 09 Nov, 2014
Many other anti-cancer photoproducts generated on the skin in addition to vitamin D – Jan 2014 19 Aug, 2014
Less intestinal cancer in mice if add vitamin D, but even less with ultraviolet light – June 2014 05 Jun, 2014
Cancer incidence in 87 countries is related to food, smoking, alcohol, GDP, and UVB - Jan 2014 08 Jan, 2014
Too much UVB: skin cancer, too little UVB: other cancers due to low vitamin D – April 2012 18 Nov, 2013
4 uses of tanning beds per year did not reduce rate of internal cancers – Oct 2013 16 Oct, 2013
Solar UVB reduces Cancer Risk – Grant, Jan 2013 02 Oct, 2013
Eye cancer and UV – Review of controversy – Sept 2013 09 Sep, 2013
Less UV: 2X more breast cancer – June 2011 08 Jul, 2013
More UVB is associated with less cancer – study of 450,000 people – April 2012 13 Apr, 2013
Some childhood cancer 30% less likely in parts of California with more UVB – April 2013 13 Apr, 2013
Texas company claimed tanning beds prevent cancer – had to pay 142,000 dollar fine – March 2013 13 Mar, 2013
China has documented that less UV results in more cancer – June 2010 07 Jan, 2013
The sun appears better at reducing incidence of some cancers than vitamin D – Dec 2012 17 Dec, 2012
Vitamin D protects mouse from skin cancer – Sept 2012 29 Nov, 2012
UVB and vitamin D inversely associated with pancreatic cancer April 2010 31 Oct, 2012
Lack of solar UVB in US is associated with some Cancers - 2006 28 Dec, 2011
Some cancer due to low UV – Grant – April 2010 13 Oct, 2011

Gastric Cancer may need Gut-Friendly Vitamin D



Created by admin. Last Modification: Thursday November 10, 2022 18:41:07 GMT-0000 by admin. (Version 27)

Attached files

ID Name Comment Uploaded Size Downloads
18789 Gastric difference.jpg admin 10 Nov, 2022 18:35 18.96 Kb 20
18788 Gastric Meta Nov_CompressPdf.pdf PDF 2022 admin 10 Nov, 2022 18:34 357.02 Kb 4
18625 GC Meta.jpg admin 11 Oct, 2022 22:31 47.88 Kb 82
18624 d2729198-35cf-46e2-8d7e-d266bd611001.pdf admin 11 Oct, 2022 21:11 364.91 Kb 28
18623 Gastric Cancer and Vitamin D genes.pdf admin 11 Oct, 2022 20:32 311.15 Kb 32
18622 Gastric meta 2015.pdf admin 11 Oct, 2022 20:26 668.30 Kb 32
18621 gastric Sci-Hub_CompressPdf.pdf admin 11 Oct, 2022 20:14 363.72 Kb 29
See any problem with this page? Report it (WORKS NOV 2021)